Aurinvest
33
3M
24
1.57
4
0.27
5
- Stages of investment
- Areas of investment
Summary
In 2001 was created Aurinvest, which is appeared as VC. The venture was found in Europe in France. The leading representative office of defined VC is situated in the Paris.
The overall number of key employees were 1.
Among the various public portfolio startups of the fund, we may underline Anaconda Pharma, Beevibes, Adamence Among the most successful fund investment fields, there are Internet, E-Commerce. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Aurinvest, startups are often financed by Kurma Partners, Microsoft Accelerator Paris, Idinvest Partners. The meaningful sponsors for the fund in investment in the same round are Idinvest Partners, Bpifrance, Kurma Partners. In the next rounds fund is usually obtained by Idinvest Partners, Kurma Partners, Bpifrance.
The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in 2-6 deals per year. Comparing to the other companies, this Aurinvest performs on 12 percentage points less the average number of lead investments. The top amount of exits for fund were in 2016. The high activity for fund was in 2015. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies.
Investments analytics
Analytics
- Total investments
- 33
- Lead investments
- 4
- Exits
- 5
- Rounds per year
- 1.57
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (8)
- Software (7)
- SaaS (6)
- Health Care (6)
- Enterprise Software (5) Show 63 more
- Investments by region
-
- France (27)
- United States (5)
- Belgium (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.67
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
PathoQuest | 11 Jul 2013 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 4M | Ile-de-France, Paris, France |
PathoQuest | 09 Nov 2021 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 17M | Ile-de-France, Paris, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.